Takashi Ebihara | GeneFrontier Corp.
GeneFrontier Corp.

Takashi Ebihara, GeneFrontier Corp., GeneFrontier Corp.

The COO of GeneFrontier Corporation since 2010, with a focus on advancing cell-free protein expression technologies, particularly the PURE system. Earned a Ph.D. in cell-free protein synthesis from Tokyo Institute of Technology in 2000, and played a key role in the establishment of GeneFrontier in 2003, leveraging his deep expertise in cell-free protein synthesis following experience in life science venture capital.

Appearances:



Festival of Biologics Day 1 @ 14:50

Cell‑Free Antibody Engineering: Accelerating Discovery and Screening with PUREfrex®

PUREfrex® is a fully reconstituted, cell‑free protein expression system enabling rapid, high‑throughput antibody engineering. It efficiently produces scFv, Fab, and IgG, and supports robust ribosome display (PUREfrexRD) for screening highly diverse libraries. Combined with AI/ML workflows, PUREfrex® accelerates discovery of next‑generation antibodies and cyclic peptide modalities with enhanced precision, flexibility, and scalability for biologics R&D.

last published: 18/Nov/26 17:29 GMT

back to speakers

Get involved at Festival of Biologics USA 2027

 

 

TO SPONSOR


Nicholas Matthews

Nicholas.Matthews@terrapinn.com

 

 

TO SPEAK


Jack Beard
Jack.Beard@terrapinn.com

 

MARKETING & PRESS


Ollie McDaid

Ollie.Mcdaid@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.